Kevin Hart, Matt Damon, Pedro Pascal invest in Function Health

Function Health, a health platform company, has secured $53 million in funding from Andreessen Horowitz and a few A-list celebrities, the company said Tuesday.

The company sells a subscription-based service that allows consumers to undergo more than 100 lab tests and then provides analysis on their heart health, potential signals for cancer, thyroid issues, hormone levels, risk for Alzheimer’ disease, kidney health and other diseases. Function uses in-house clinicians and some from telehealth company SteadyMD to write clinical insights based on the lab work. A doctor will call a patient if there is an emergency indicated within the results.

Related: Healthcare AI investment is on the rise: 5 things to know

Venture capital firm Andreessen Horowitz, which has had a busy few weeks in digital health, led the round. Other investors included actors Matt Damon, Zac Efron, Pedro Pascal and Kevin Hart along with former and current NBA stars Joel Embiid and Blake Griffin, former NFL star Colin Kaepernick, podcast host Jay Shetty. 

The company has 50,000 subscribers and a waiting list of more than 200,000 people, said CEO Dr. Mark Hyman. He attributed those numbers to word of mouth and him mentioning the company on his podcast, which ranks in the top five of Apple’s health and wellness podcasts. Hyman said the company will use the $53 million to start traditional marketing and make the platform more user-friendly.

Function charges $499 for an annual subscription but is looking to expand into enterprise contracts with self-insured employers and insurance companies. The company does not accept insurance.

“We're very focused on getting into highly insured, large Fortune 500 companies and payers as well as Medicare and Medicaid,” Hyman said. “We’re focused on those markets because we believe we can show them our value proposition.”